https://arxiv.org/api/ii50p5Zo7D7OVYz8U9fuzvRjDpE 2026-06-13T23:06:36Z 3848 150 15 http://arxiv.org/abs/2603.11141v1 2026-03-11T16:40:13Z

Cross-species antimicrobial resistance (AMR) prediction is fundamentally an out-of-distribution (OOD) generalization problem: models trained on one set of bacterial taxa must transfer to phylogenetically distinct genomes that may rely on different resistance mechanisms. Across species, resistance arises from a heterogeneous mixture of localized, horizontally transferred gene cassettes and diffuse species-specific genomic backgrounds, making successful transfer inherently mechanism-dependent. Using a strict species holdout protocol, we first establish an interpretable k-mer baseline with Kover and show that strong within-species performance collapses under true cross-species evaluation. This motivates representation-level approaches that preserve transferable biological signals rather than amplify phylogenetic shortcuts. We investigate genomic foundation model embeddings derived from Evo-1-8k-base and introduce diagnostics for layer selection based on activation scale, isotropy, effective rank, and cross-seed stability under native bfloat16 inference. These analyses identify a stability boundary in deeper layers and reveal that embeddings extracted near this boundary provide more robust representations for downstream prediction. To preserve localized resistance signals, we treat per-window embeddings as an ordered multivariate signal and apply MiniRocket to summarize multi-scale local activation patterns instead of relying on global pooling. Our results show that aggregation strategy plays a central role in cross-species AMR prediction and that preserving local activation patterns substantially improves generalization when resistance mechanisms are localized.

2026-03-11T16:40:13Z Master's thesis, Columbia University, Department of Computer Science Huilin Tai http://arxiv.org/abs/2603.10885v1 2026-03-11T15:30:38Z

We present a parameter-efficient Diffusion Transformer (DiT) for generating 200bp cell-type-specific regulatory DNA sequences. By replacing the U-Net backbone of DNA-Diffusion with a transformer denoiser equipped with a 2D CNN input encoder, our model matches the U-Net's best validation loss in 13 epochs (60$\times$ fewer) and converges 39% lower, while reducing memorization from 5.3% to 1.7% of generated sequences aligning to training data via BLAT. Ablations show the CNN encoder is essential: without it, validation loss increases 70% regardless of positional embedding choice. We further apply DDPO finetuning using Enformer as a reward model, achieving a 38$\times$ improvement in predicted regulatory activity. Cross-validation against DRAKES on an independent prediction task confirms that improvements reflect genuine regulatory signal rather than reward model overfitting.

2026-03-11T15:30:38Z Jonathan Liu Kia Ghods http://arxiv.org/abs/2603.10873v1 2026-03-11T15:23:37Z

Polygenic risk scores and other genomic analyses require large individual-level genotype datasets, yet strict data access restrictions impede sharing. Synthetic genotype generation offers a privacy-preserving alternative, but most existing methods operate unconditionally, producing samples without phenotype alignment, or rely on unsupervised compression, creating a gap between statistical fidelity and downstream task utility. We present SNPgen, a two-stage conditional latent diffusion framework for generating phenotype-supervised synthetic genotypes. SNPgen combines GWAS-guided variant selection (1,024-2,048 trait-associated SNPs) with a variational autoencoder for genotype compression and a latent diffusion model conditioned on binary disease labels via classifier-free guidance. Evaluated on 458,724 UK Biobank individuals across four complex diseases (coronary artery disease, breast cancer, type 1 and type 2 diabetes), models trained on synthetic data matched real-data predictive performance in a train-on-synthetic, test-on-real protocol, approaching genome-wide PRS methods that use $2$-$6\times$ more variants. Privacy analysis confirmed zero identical matches, near-random membership inference (AUC $\approx 0.50$), preserved linkage disequilibrium structure, and high allele frequency correlation ($r \geq 0.95$) with source data. A controlled simulation with known causal effects verified faithful recovery of the imposed genetic association structure.

2026-03-11T15:23:37Z Andrea Lampis Michela Carlotta Massi Nicola Pirastu Francesca Ieva Matteo Matteucci Emanuele Di Angelantonio http://arxiv.org/abs/2512.04393v2 2026-03-11T03:22:20Z

Computing haplotypes from sequencing data, i.e. haplotype assembly, is an important component of molecular and population genetics problems, including interpreting the effects of genetic variation on complex traits and reconstructing genealogical relationships. Assembling the haplotypes of polyploid genomes remains a significant challenge due to the exponential search space of haplotype phasings and read assignment ambiguity; the latter challenge is particularly difficult for haplotype assemblers since the information contained within the observed sequence reads is often insufficient for unambiguous haplotype assignment in polyploid genomes. We present pHapCompass, probabilistic haplotype assembly algorithms for diploid and polyploid genomes that explicitly model and propagate read assignment ambiguity to compute a distribution over polyploid haplotype phasings. We develop graph theoretic algorithms to enable statistical inference and uncertainty quantification despite an exponential space of possible phasings. Since prior work evaluates polyploid haplotype assembly on synthetic genomes that do not reflect the realistic genomic complexity of polyploidy organisms, we develop a computational workflow for simulating genomes and DNA-seq for auto- and allopolyploids. Additionally, we generalize the vector error rate and minimum error correction evaluation criteria for partially phased haplotypes. Benchmarking of pHapCompass and several existing polyploid haplotype assemblers shows that pHapCompass yields competitive performance across varying genomic complexities and polyploid structures while retaining an accurate quantification of phase uncertainty. The source code for pHapCompass, simulation scripts, and datasets are freely available at https://github.com/bayesomicslab/pHapCompass.

2025-12-04T02:28:35Z Marjan Hosseini School of Computing, University of Connecticut Ella Veiner School of Computing, University of Connecticut Thomas Bergendahl School of Computing, University of Connecticut Tala Yasenpoor School of Computing, University of Connecticut Zane Smith Department of Entomology and Plant Pathology, University of Tennessee Margaret Staton Department of Entomology and Plant Pathology, University of Tennessee Derek Aguiar School of Computing, University of Connecticut Institute for Systems Genomics, University of Connecticut http://arxiv.org/abs/2603.10261v1 2026-03-10T22:44:12Z

We report the discovery and extraction of a compact hematopoietic algorithm from the single-cell foundation model scGPT, to our knowledge the first biologically useful, competitive algorithm extracted from a foundation model via mechanistic interpretability. We show that scGPT internally encodes a compact hematopoietic manifold with significant developmental branch structure, validated on a strict non-overlap Tabula Sapiens external panel and confirmed via frozen-head zero-shot transfer to an independent multi-donor immune panel. To isolate this geometry, we introduce a general three-stage extraction method consisting of direct operator export from frozen attention weights, a lightweight learned adaptor, and a task-specific readout, producing a standalone algorithm without target-dataset retraining. In 88-split donor-holdout benchmarks against scVI, Palantir, DPT, CellTypist, PCA, and raw-expression baselines, the extracted algorithm achieves the strongest pseudotime-depth ordering and leads on key subtype endpoints (CD4/CD8 AUROC 0.867, mono/macro AUROC 0.951). Compared to standard probing of frozen scGPT embeddings with a 3-layer MLP, the extracted head is BH-significantly better on 6/8 classification endpoints while completing a full 12-split evaluation campaign 34.5x faster with approximately 1000x fewer trainable parameters. The exported operator compresses from three pooled attention heads to a single head without statistically significant loss, and further to a rank-64 surrogate. Mechanistic interpretability of the compact operator reveals a concentrated four-factor core explaining 66.2% of ablation impact, with factors resolving into explicit T/lymphoid, B/plasma, granulocytic, and monocyte/macrophage gene programs. A supplementary second-manifold validation (intercellular communication geometry) confirms that the extraction method generalizes beyond hematopoiesis.

2026-03-10T22:44:12Z Ihor Kendiukhov http://arxiv.org/abs/2603.08913v1 2026-03-09T20:30:37Z

Genomic language models (GLMs) have emerged as powerful tools for learning representations of DNA sequences, enabling advances in variant prediction, regulatory element identification, and cross-task transfer learning. However, as these models are increasingly trained or fine-tuned on sensitive genomic cohorts, they risk memorizing specific sequences from their training data, raising serious concerns around privacy, data leakage, and regulatory compliance. Despite growing awareness of memorization risks in general-purpose language models, little systematic evaluation exists for these risks in the genomic domain, where data exhibit unique properties such as a fixed nucleotide alphabet, strong biological structure, and individual identifiability. We present a comprehensive, multi-vector privacy evaluation framework designed to quantify memorization risks in GLMs. Our approach integrates three complementary risk assessment methodologies: perplexity-based detection, canary sequence extraction, and membership inference. These are combined into a unified evaluation pipeline that produces a worst-case memorization risk score. To enable controlled evaluation, we plant canary sequences at varying repetition rates into both synthetic and real genomic datasets, allowing precise quantification of how repetition and training dynamics influence memorization. We evaluate our framework across multiple GLM architectures, examining the relationship between sequence repetition, model capacity, and memorization risk. Our results establish that GLMs exhibit measurable memorization and that the degree of memorization varies across architectures and training regimes. These findings reveal that no single attack vector captures the full scope of memorization risk, underscoring the need for multi-vector privacy auditing as a standard practice for genomic AI systems.

2026-03-09T20:30:37Z 13 pages Alexander Nemecek Wenbiao Li Xiaoqian Jiang Jaideep Vaidya Erman Ayday http://arxiv.org/abs/2502.03569v3 2026-03-09T14:46:46Z

Conditional generation models for longitudinal sequences can produce new or modified trajectories given a conditioning input. However, they often lack control over when the condition should take effect (timing) and which variables it should influence (scope). Most methods either operate only on univariate sequences or assume that the condition alters all variables and time steps. In scientific and clinical settings, interventions instead begin at a specific moment, such as the time of drug administration or surgery, and influence only a subset of measurements while the rest of the trajectory remains unchanged. CLEF learns temporal concepts that encode how and when a condition alters future sequence evolution. These concepts allow CLEF to apply targeted edits to the affected time steps and variables while preserving the rest of the sequence. We evaluate CLEF on 8 datasets spanning cellular reprogramming, patient health, and sales, comparing against 9 state-of-the-art baselines. CLEF improves immediate sequence editing accuracy by 16.28% (MAE) on average against their non-CLEF counterparts. Unlike prior models, CLEF enables one-step conditional generation at arbitrary future times, outperforming their non-CLEF counterparts in delayed sequence editing by 26.73% (MAE) on average. We test CLEF under counterfactual inference assumptions and show up to 62.84% (MAE) improvement on zero-shot conditional generation of counterfactual trajectories. In a case study of patients with type 1 diabetes mellitus, CLEF identifies clinical interventions that generate realistic counterfactual trajectories shifted toward healthier outcomes.

2025-02-05T19:33:12Z ICLR 2026 Michelle M. Li Kevin Li Yasha Ektefaie Ying Jin Yepeng Huang Shvat Messica Tianxi Cai Marinka Zitnik http://arxiv.org/abs/2512.05731v2 2026-03-09T11:07:33Z

Summary: Modern omics experiments now involve multiple conditions and complex designs, producing an increasingly large set of differential expression and functional enrichment analysis results. However, no standardized data structure exists to store and contextualize these results together with their metadata, leaving researchers with an unmanageable and potentially non-reproducible collection of results that are difficult to navigate and/or share. Here we introduce DeeDeeExperiment, a new S4 class for managing and storing omics data analysis results, implemented within the Bioconductor ecosystem, which promotes interoperability, reproducibility and good documentation. This class extends the widely used SingleCellExperiment object by introducing dedicated slots for Differential Expression (DEA) and Functional Enrichment Analysis (FEA) results, allowing users to organize, store, and retrieve information on multiple contrasts and associated metadata within a single data object, ultimately streamlining the management and interpretation of many omics datasets. Availability and implementation: DeeDeeExperiment is available on Bioconductor under the MIT license (https://bioconductor.org/packages/DeeDeeExperiment), with its development version also available on Github (https://github.com/imbeimainz/DeeDeeExperiment).

2025-12-05T14:11:28Z 1 figure Najla Abassi Lea Schwarz Edoardo Filippi Federico Marini http://arxiv.org/abs/2603.08062v1 2026-03-09T07:55:32Z

Accurate phenotype prediction from RNA sequencing (RNA-seq) data is essential for diagnosis, biomarker discovery, and personalized medicine. Deep learning models have demonstrated strong potential to outperform classical machine learning approaches, but their performance relies on large, well-annotated datasets. In transcriptomics, such datasets are frequently limited, leading to over-fitting and poor generalization. Knowledge transfer from larger, more general datasets can alleviate this issue. However, transferring information across RNA-seq datasets remains challenging due to heterogeneous preprocessing pipelines and differences in target phenotypes. In this study, we propose a deep learning-based domain adaptation framework that enables effective knowledge transfer from a large general dataset to a smaller one for cancer type classification. The method learns a domain-invariant latent space by jointly optimizing classification and domain alignment objectives. To ensure stable training and robustness in data-scarce scenarios, the framework is trained with an adversarial approach with appropriate regularization. Both supervised and unsupervised approach variants are explored, leveraging labeled or unlabeled target samples. The framework is evaluated on three large-scale transcriptomic datasets (TCGA, ARCHS4, GTEx) to assess its ability to transfer knowledge across cohorts. Experimental results demonstrate consistent improvements in cancer and tissue type classification accuracy compared to non-adaptive baselines, particularly in low-data scenarios. Overall, this work highlights domain adaptation as a powerful strategy for data-efficient knowledge transfer in transcriptomics, enabling robust phenotype prediction under constrained data conditions.

2026-03-09T07:55:32Z 7 pages, 5 figures. Submitted to ECCB 2026 Kevin Dradjat Massinissa Hamidi Blaise Hanczar http://arxiv.org/abs/2511.08996v3 2026-03-08T17:33:31Z

Accurate cell type annotation across datasets is a key challenge in single-cell analysis. snRNA-seq enables profiling of frozen or difficult-to-dissociate tissues, complementing scRNA-seq by capturing fragile or rare cell types. However, cross-annotation between these two datasets remains largely unexplored, as existing methods treat them independently. We introduce ScNucAdapt, a method designed for cross-annotation between paired and unpaired scRNA-seq and snRNA-seq datasets. To address distributional and cell composition differences, ScNucAdapt employs partial domain adaptation. Experiments across both unpaired and paired scRNA-seq and snRNA-seq show that ScNucAdapt achieves robust and accurate cell type annotation, outperforming existing approaches. Therefore, ScNucAdapt provides a practical framework for the cross-domain cell type annotation between scRNA-seq and snRNA seq data.

2025-11-12T05:37:40Z Xiran Chen Quan Zou Qinyu Cai Xiaofeng Chen Weikai Li Yansu Wang http://arxiv.org/abs/2603.06950v1 2026-03-06T23:52:26Z

DNA foundation models have become transformative tools in bioinformatics and healthcare applications. Trained on vast genomic datasets, these models can be used to generate sequence embeddings, dense vector representations that capture complex genomic information. These embeddings are increasingly being shared via Embeddings-as-a-Service (EaaS) frameworks to facilitate downstream tasks, while supposedly protecting the privacy of the underlying raw sequences. However, as this practice becomes more prevalent, the security of these representations is being called into question. This study evaluates the resilience of DNA foundation models to model inversion attacks, whereby adversaries attempt to reconstruct sensitive training data from model outputs. In our study, the model's output for reconstructing the DNA sequence is a zero-shot embedding, which is then fed to a decoder. We evaluated the privacy of three DNA foundation models: DNABERT-2, Evo 2, and Nucleotide Transformer v2 (NTv2). Our results show that per-token embeddings allow near-perfect sequence reconstruction across all models. For mean-pooled embeddings, reconstruction quality degrades as sequence length increases, though it remains substantially above random baselines. Evo 2 and NTv2 prove to be most vulnerable, especially for shorter sequences with reconstruction similarities > 90%, while DNABERT-2's BPE tokenization provides the greatest resilience. We found that the correlation between embedding similarity and sequence similarity was a key predictor of reconstruction success. Our findings emphasize the urgent need for privacy-aware design in genomic foundation models prior to their widespread deployment in EaaS settings. Training code, model weights and evaluation pipeline are released on: https://github.com/not-a-feature/DNA-Embedding-Inversion.

2026-03-06T23:52:26Z Sofiane Ouaari Jules Kreuer Nico Pfeifer http://arxiv.org/abs/2603.06804v1 2026-03-06T19:13:19Z

Identifying disease-associated genes enables the development of precision medicine and the understanding of biological processes. Genome-wide association studies (GWAS), gene expression data, biological pathway analysis, and protein network analysis are among the techniques used to identify causal genes. We propose a machine-learning (ML) and deep-learning (DL) pipeline to identify genes associated with a phenotype. The proposed pipeline consists of two interrelated processes. The first is classifying people into case/control based on the genotype data. The second is calculating feature importance to identify genes associated with a particular phenotype. We considered 30 phenotypes from the openSNP data for analysis, 21 ML algorithms, and 80 DL algorithms and variants. The best-performing ML and DL models, evaluated by the area under the curve (AUC), F1 score, and Matthews correlation coefficient (MCC), were used to identify important single-nucleotide polymorphisms (SNPs), and the identified SNPs were compared with the phenotype-associated SNPs from the GWAS Catalog. The mean per-phenotype gene identification ratio (GIR) was 0.84. These results suggest that SNPs selected by ML/DL algorithms that maximize classification performance can help prioritise phenotype-associated SNPs and genes, potentially supporting downstream studies aimed at understanding disease mechanisms and identifying candidate therapeutic targets.

2026-03-06T19:13:19Z Muhammad Muneeb David B. Ascher YooChan Myung http://arxiv.org/abs/2602.10152v2 2026-03-06T15:55:21Z

Saliency maps are increasingly used as design guidance in siRNA efficacy prediction, yet attribution methods are rarely validated before motivating sequence edits. We introduce a pre-synthesis gate: a protocol for counterfactual sensitivity faithfulness that tests whether mutating high-saliency positions changes model output more than composition-matched controls. Cross-dataset transfer reveals two failure modes that would otherwise go undetected: faithful-but-wrong (saliency valid, predictions fail) and inverted saliency (top-saliency edits less impactful than random). Strikingly, models trained on mRNA-level assays collapse on a luciferase reporter dataset, demonstrating that protocol shifts can silently invalidate deployment. Across four benchmarks, 19/20 fold instances pass; the single failure shows inverted saliency. A biology-informed regularizer (BioPrior) strengthens saliency faithfulness with modest, dataset-dependent predictive trade-offs. Our results establish saliency validation as essential pre-deployment practice for explanation-guided therapeutic design. Code is available at https://github.com/shadi97kh/BioPrior.

2026-02-09T19:27:42Z Accepted at the Machine Learning for Genomics Explorations (MLGenX) Workshop at ICLR 2026 ICLR 2026 Workshop on Machine Learning for Genomics Explorations (MLGenX) Zahra Khodagholi Niloofar Yousefi http://arxiv.org/abs/2507.19229v2 2026-03-06T10:49:55Z

The modeling of genomic sequences presents unique challenges due to their length and structural complexity. Traditional sequence models struggle to capture long-range dependencies and biological features inherent in DNA. In this work, we propose TrinityDNA, a novel DNA foundational model designed to address these challenges. The model integrates biologically informed components, including Groove Fusion for capturing DNA's structural features and Gated Reverse Complement (GRC) to handle the inherent symmetry of DNA sequences. Additionally, we introduce a multi-scale attention mechanism that allows the model to attend to varying levels of sequence dependencies, and an evolutionary training strategy that progressively adapts the model to both prokaryotic and eukaryotic genomes. TrinityDNA provides a more accurate and efficient approach to genomic sequence modeling, offering significant improvements in gene function prediction, regulatory mechanism discovery, and other genomics applications. Our model bridges the gap between machine learning techniques and biological insights, paving the way for more effective analysis of genomic data. Additionally, we introduced a new DNA long-sequence CDS annotation benchmark to make evaluations more comprehensive and oriented toward practical applications.

2025-07-25T12:55:30Z AAAI 2026 Qirong Yang Yucheng Guo Zicheng Liu Yujie Yang Qijin Yin Siyuan Li Shaomin Ji Linlin Chao Xiaoming Zhang Stan Z. Li http://arxiv.org/abs/2511.02263v4 2026-03-05T22:52:04Z

Rare disease diagnosis requires matching variant-bearing genes to complex patient phenotypes across large and heterogeneous evidence sources. This process remains time-intensive in current clinical interpretation pipelines. To overcome these limitations, We present LA-MARRVEL, a knowledge-grounded, language-aware LLM framework and designed for clinical robustness and practical deployment. LA-MARRVEL delivers a 12-15 percentage-point absolute improvement in Recall@1 over established gene prioritization approaches, showing that architectural design can drive substantial accuracy gains. We found that the central contributor is structured, phenotype-rich prompt construction that explicitly encodes patient and disease phenotypes, preserving clinically meaningful context more effectively than disease labels alone. Across three real-world cohorts, LA-MARRVEL consistently improves gene-ranking performance, including in challenging cases where the causal gene was initially ranked lower by first-stage prioritization. For each candidate gene, the system delivers clinically relevant, ACMG-aligned reasoning that integrates phenotype concordance, inheritance patterns, and variant-level evidence into auditable explanations, enabling streamlined clinical review. These findings suggest that knowledge-grounded LLM layer can enhance existing rare-disease gene prioritization workflows without altering established diagnostic pipelines.

2025-11-04T05:17:41Z Jaeyeon Lee Lin Yao Hyun-Hwan Jeong Zhandong Liu